World Antipsychotic Drugs Market - Opportunities and Forecasts, 2020-2027
|
LI_18437
|
Pages: NA
|
Mar 2020 |
6930 Views
|
|
|
|
Author(s) :
NA
|
Tables: NA
|
Charts: NA
|
Formats*:
|
|
Antipsychotic drugs are also termed as major tranquilizers or neuroleptics and these are primarily used to treat psychosis. The common psychotic disorders, where these drugs are majorly used include schizophrenia, hallucinations, delusions, bipolar disorder and others. The antipsychotic drugs market is expected to grow due to the rising number of Schizophrenic patients. However, patent expiration of major brands could negatively impact the market growth. Deep-dive analysis of global antipsychotic drugs market focuses on major market dynamics such as drivers, restrains and opportunities. Competitive landscape section profiles the key players on the basis of business performance, strategic moves and SWOT analysis. Profound analysis of segments would be helpful to understand the product distribution trends in each segment within the global antipsychotic drugs market.
High prevalence of Schizophrenia and psychotic disorders are the prime drivers for global antipsychotic drugs market. Increased drug abuse, over prescription of drugs and addiction to antipsychotic drugs are the additional factors that drive the market growth for antipsychotic drugs. However, patent expiry of major brands over the past few years had negative impact on market growth and it has been responsible to the rising competition from generic drug manufacturer. Serious side effects such as tardive dyskinesia, associated with antipsychotics also restraints the market growth. Emerging economies are the opportunistic markets for antipsychotics due to large pool of aging population, which has high risk of psychosis, and increased healthcare awareness.
Global Antipsychotic Drugs Market by Brands
The global antipsychotic drugs market is segmented into three categories based on brands such as First, Second and Third generation antipsychotic drugs. Except Halodol and lithium carbonate, all first generation antipsychotic agents are called as standard or typical antipsychotics, as they act similar i.e., interference with neurotransmitters. Second generation antipsychotics are also known as atypical antipsychotic agents and act as broad-spectrum antagonists of dopamine, serotonin and alpha-noradrenergic receptors. With development of technology and growing competition to gain largest market share, researchers are focusing on first generation antipsychotics to better understand their working mechanism. Abilify and Seroquel are topmost marketed brands due their high therapeutic efficacy and reduced side effects.
Global Antipsychotic Drugs Market by Application
The global antipsychotic drugs are used to treat different brain disorders such as Schizophrenia, Bipolar disorder, Dementia, Unipolar Depression and Others. The drugs used in Schizophrenia and psychotic depression are expected to boost the growth of antipsychotic drugs market due to increasing incidences of these two conditions.
Global Antipsychotic Drugs Market by Geography
Geographically, global antipsychotic drugs market is segmented into North America, Europe, Asia-Pacific and LAMEA. Antipsychotics are the largely prescribed drugs in the North American region due to large patient pool suffering from mental and psychotic disorders. Asia-Pacific and LAMEA are the lucrative market for global antipsychotic drugs manufacturers, due to large patient pool and rising healthcare awareness.
Competitive Landscape
The key players within global antipsychotic drugs market include Eli Lilly, AstraZeneca, Pfizer, Bristol-Myers Squibb, GlaxoSmithKline and Johnson & Johnson. Patent expiration of major brands such as Zyprexa (by Eli Lilly) and Seroquel (by AstraZeneca) has negatively impacted the total revenue of this maket. Generic competition is soaring due to patent expiration of six largest antipsychotic drugs in 2012.
High Level Analysis
The comprehensive analysis of global antipsychotic drugs market provides an overview of the market and its key concerns. Market segmentation is concentric towards product distribution trends of each segment that would be helpful to strategist in deciding on the market segments. Market dynamics covers market drivers, restrains and opportunities, which would help to understand the market behaviour. Porter’s Five Forces analysis would be helpful in determining the market profitability. Buyers bargaining power is high for global antipsychotic drugs market due to patent expiration of major brands and availability of many generic medicines in the marketplace. Global antipsychotic drugs market has high threat from new entrants as major brands have lost their patent protection in 2012. Industrial rivalry is intense due to entry of numerous generic competitors, which forces big players to manipulate their drug prices according to changing market trends.
KEY BENEFITS
This report offers the following benefits in particular:
Complete analysis of drivers, restrains and opportunities within global antipsychotic drugs market would assist professionals to understand the market behavior
Profound assessment of geography focuses on niche market areas and provides forward looking perspective
Porter’s Five Forces framework would assist strategist in decision making by analyzing the market profitability within global antipsychotic drugs market
Comprehensive assessment of key leaders and their market strategies for global antipsychotic drugs market would be informative to professionals in the corporate sector
KEY DELIVERABLES
The global antipsychotic drugs market is segmented into two major categories such as technology and geography.
MARKET BY BRANDS
First Generation Drugs (Standard / Typical Antipsychotic Agents)
Thorazine (Chlorpromazine HCl)
Serentil (Mesoridazine Besylate)
Mellaril (Thioridazine HCl)
Haldol (Haloperidol)
Loxitane (Loxapine Succinate)
Trilafon (Perphenazine)
Navane (Thiothixene)
Sordinol (Clopenthixol)
Others
Second generation Drugs (Atypical Antipsychotic Agents)
Zyprexa (Olanzapine)
Geodon (Ziprasidone)
Seroquel (Quetiapine)
Risperdal (Risperidone)
Clozaril (Clozapine)
Invega (Paliperidone)
Asendin (Amoxapine)
Latuda (Lurasidone)
Others
Third generation Drugs
Abilify (Aripiprazole)
MARKET BY APPLICATION
Schizophrenia
Bipolar Disorder
Dementia
Unipolar Depression
Other
MARKET BY GEOGRAPHY
North America
We offer our clients exhaustive research and analysis based on wide variety of factual inputs, which largely include interviews with industry participants, reliable statistics and regional intelligence. Our in-house industry experts play instrumental role in designing analytic tools and models, tailored to the requirements of particular industry segment. These analytical tools and models sanitize the data & statistics and enhance the accuracy of our recommendations and advice. With AMR’s calibrated research process and 360` degree data-evaluation methodology, our clients are assured of receiving:
- Consistent, valuable, robust and actionable data & analysis that can easily be referenced for strategic business planning
- Technologically sophisticated and reliable insights through well audited and veracious research methodology
- Sovereign research proceeds that present a tangible depiction of marketplace
With a strong methodology we are, therefore, confident that our research and analysis are most reliable and guarantees sound business planning.
Secondary research
We refer a broad array of industry sources for our secondary, which typically include; however, not limited to: Company SEC filings, annual reports, company websites, broker & financial reports and investor presentations for competitive scenario and shape of the industry
- Patent and regulatory databases for understanding of technical & legal developments
- Scientific and technical writings for product information and related preemptions
- Regional government and statistical databases for macro analysis
- Authentic new articles, web-casts and other related releases for market evaluation
- Internal and external proprietary databases, key market indicators and relevant press releases for market estimates and forecast
Primary research
Our primary research efforts include reaching out participants through mail, tele-conversations, referrals, professional networks and face-to-face interactions. We are also in professional corporate relations with various companies that allow us greater flexibility for reaching out industry participants and commentators for interviews and discussions, fulfilling following functions:
- Validates and improves the data quality and strengthens research proceeds
- Further develops analyst team’s market understanding and expertise
- Supplies authentic information about market size, share, growth and forecasts
Our primary research interview and discussion panels are typically composed of most experienced industry members. These participants include; however, not limited to:
- Chief executives and VPs of leading corporations specific to industry
- Product and sales managers or country heads; channel partners and top level distributors; banking, investments and valuation experts Key opinion leaders (KOLs)
Analyst tools and models
AMR has developed set of analyst tools and data models to supplement and expedite the analysis process. Corresponding to markets, where there is significant lack of information and estimates, AMR’s team of experts and analyst develop specific analyst tools and industry models to translate qualitative and quantitative industry indicators into exact industry estimates. These models also allow analysts to examine the prospects and opportunities prevailing in the market to accurately forecast the course of the market.
REQUEST TOC/SAMPLE
Purchase Full Report of
World Antipsychotic Drugs Market-
Opportunities and Forecasts, 2020-2027
- Online Only
-
$3,456$3,110 - Online cloud access only
- Restricted print, copy, paste & download
- Read only
- Free quarterly industry update
- Free report update (Within 180 days)
- Subscription model sign in
- Data Pack
-
$3,840$3,456 - Restricted to one authorized user
- One print only
- Available in
Excel - Free quarterly industry update
- Free report update (Within 180 days)
- Subscription model sign in
- Single User
-
$5,370$4,833 - Restricted to one authorized user
- One print only
- Available in Excel & PDF
- Free quarterly industry update
- Free report update (Within 180 days)
- Subscription model sign in
- Five Users
-
$6,450$5,805 - Limited to five authorized users
- Print upto five copies
- Available in Excel & PDF
- Free quarterly industry update
- Free report update (Within 180 days)
- Subscription model sign in
-
Enterprise
License/PDF -
$8,995$8,096 - Unlimited
within
company/enterprise - Available in Excel & PDF
- Free quarterly industry update
- Free report update (Within 180 days)
- Subscription model sign in
- Library Membership
- $0.00
- Published Content
E-access - Company Profiles
E-access - Newly Added Content Access
- 10 PDF
Downloads - 5 Excel Data
Pack Downloads - 250 Company Profiles PDF Downloads
-
Start reading.
Buy Now
This title and over 12,000+ are available on the Avenue Library. Subscription @ $559 T&C*.
*Taxes/Fees, if applicable will be added during checkout. All prices in USD
Why Allied Market Research?
Infallible Methodology
To ensure high-level data integrity, accurate analysis, and impeccable forecasts
Analyst Support
For complete satisfaction
Customization
On-demand customization of scope of the report to exactly meet your needs
TARGETED MARKET VIEW
Targeted market view to provide pertinent information and save time of readers
Get fresh content delivered
Get insights on topics that are crucial for your business. Stay abreast of your interest areas.